Reorganization of Cholinergic Terminals in the Cerebral Cortex and Hippocampus in Transgenic Mice Carrying Mutated Presenilin-1 and Amyloid Precursor Protein Transgenes

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043

Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757

Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels

Köhler, C., Ebert, U., Baumann, K., & Schröder, H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.009 · Cited by 37

Glutamate Receptor Dysregulation in the Hippocampus of Transgenic Mice Carrying Mutated Human Amyloid Precursor Protein

Cha, J.-H. J., Farrell, L. A., Ahmed, S. F., Frey, A. S., Ashe, K. H., Young, A. B., Penney, J. B., Locascio, J. J., Hyman, B. T., & Irizarry, M. C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0330 · Cited by 37

The Functions of the Amyloid Precursor Protein Gene

Panegyres, P. K. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.1.1 · Cited by 36

The effect of aging on the subcellular distribution of estrogen receptor‐alpha in the cholinergic neurons of transgenic and wild‐type mice

Kalesnykas, G., Roschier, U., Puoliväli, J. T., Wang, J., & Miettinen, R. A. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03953.x · Cited by 35

The acetylcholine innervation of cerebral cortex: new data on its normal development and its fate in the hAPPSW,IND mouse model of Alzheimer?s disease

Descarries, L., Aznavour, N., & Hamel, É. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0186-z · Cited by 34

Early changes in neurons of the hippocampus and neocortex in transgenic rats expressing intracellular human a-β

Serrano-López, E. M., Bell, K. F. S., Ribeiro‐da‐Silva, A., & Cuello, A. C. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6410 · Cited by 36

Ganglioside Metabolism in a Transgenic Mouse Model of Alzheimer’s Disease: Expression of Chol-1α Antigens in the Brain

Ariga, T., Yanagisawa, M., Wakade, C. G., Ando, S., Buccafusco, J. J., McDonald, M. P., & Yu, R. K. (2010) · ASN NEURO · doi:10.1042/an20100021 · Cited by 33

Object Recognition Memory and Cholinergic Parameters in Mice Expressing Human Presenilin 1 Transgenes

Vaucher, E., Fluit, P., Chishti, M. A., Westaway, D. A., Mount, H. T. J., & Kar, S. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7915 · Cited by 36

The α7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice

Ren, K., King, M. A., Liu, J., Siemann, J. K., Altman, M., Meyers, C., Hughes, J. A., & Meyer, E. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.013 · Cited by 34

Elevated Levels of miR-144-3p Induce Cholinergic Degeneration by Impairing the Maturation of NGF in Alzheimer’s Disease

Zhou, L., Zhang, J., Tan, L., Huang, H., Zhou, Y., Liu, Z., Lu, Y., Zhu, L., Yao, C., & Liu, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667412 · Cited by 33

Alzheimer’s Disease in Man and Transgenic Mice

Turner, R. S. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64026-6 · Cited by 31

Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome

Aranha, M. R., Iulita, M. F., Montal, V., Pegueroles, J., Bejanin, A., Vaqué‐Alcázar, L., Grothe, M. J., Carmona‐Iragui, M., Videla, L., Benejam, B., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12999 · Cited by 30

Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer’s Disease

Müller, L., Kirschstein, T., Köhling, R., Kuhla, A., & Teipel, S. J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201540 · Cited by 27

Impaired neurotransmitter systems by Aβ amyloidosis in APPsw transgenic mice overexpressing amyloid β protein precursor

Tomidokoro, Y., Harigaya, Y., Matsubara, E., Ikeda, M., Kawarabayashi, T., Okamoto, K., & Shoji, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01443-9 · Cited by 27

Enhanced accumulation of phosphorylated α‐synuclein in double transgenic mice expressing mutant β‐amyloid precursor protein and presenilin‐1

Kurata, T., Kawarabayashi, T., Murakami, T., Miyazaki, K., Morimoto, N., Ohta, Y., Takehisa, Y., Nagai, M., Ikeda, M., Matsubara, E., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21352 · Cited by 26

Transgenic mouse models of Alzheimer's disease: phenotype and mechanisms of pathogenesis

Duff, K. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670195 · Cited by 27

Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model

Nikolajsen, G. N., Jensen, M. S., & West, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.006 · Cited by 25

NGF-Dependent Changes in Ubiquitin Homeostasis Trigger Early Cholinergic Degeneration in Cellular and Animal AD-Model

Latina, V., Caioli, S., Zona, C., Ciotti, M. T., Borreca, A., Calissano, P., & Amadoro, G. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00487 · Cited by 26

Does Anticholinergic Activity Affect Neuropathology Implication of Neuroinflammation in Alzheimer's Disease

Yoshiyama, Y., Kojima, A., Itoh, K., Isose, S., Koide, M., Hori, K., & Arai, K. (2015) · Neurodegenerative Diseases · doi:10.1159/000381484 · Cited by 24

Neurobiological and genetic correlates of the dissociative subtype of posttraumatic stress disorder.

Wolf, E. J., Hawn, S. E., Sullivan, D. R., Miller, M. W., Sanborn, V., Brown, E., Neale, Z., Fein-Schaffer, D., Zhao, X., Logue, M. W., et al. (2023) · Journal of Psychopathology and Clinical Science · doi:10.1037/abn0000795 · Cited by 23

Elevated levels of Aβ1–40 and Aβ1–42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice

Marutle, A., Unger, C., Hellström‐Lindahl, E., Wang, J., Puoliväli, J. T., Tanila, H., Nordberg, A. K., & Zhang, X. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00546-3 · Cited by 23

Overview and perspective on the therapy of alzheimer's disease from a preclinical viewpoint

Pepeu, G. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00146-4 · Cited by 23

Reduced density of neuropeptide Y neurons in the somatosensory cortex of old male and female rats: Relation to cholinergic depletion and recovery after nerve growth factor treatment

Cardoso, A., Paula-Barbosa, M. M., & Lukoyanov, N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.027 · Cited by 24

Reduction in CHT1-mediated choline uptake in primary neurons from presenilin-1 M146V mutant knock-in mice

Payette, D. J., Xie, J., & Guo, Q. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.005 · Cited by 20

Coexisting Cholinergic and Parahippocampal Degeneration: A Key to Memory Loss in Dementia and a Challenge for Transgenic Models?

Cassel, J., Mathis, C., Majchrzak, M. J., Moreau, P., & Dalrymple‐Alford, J. C. (2008) · Neurodegenerative Diseases · doi:10.1159/000135615 · Cited by 21

Effect of Neocortical and Hippocampal Amyloid Deposition upon Galaninergic and Cholinergic Neurites in AβPPswe/PS1ΔE9 Mice

Kelley, C. M., Perez, S. E., Overk, C., Wynick, D., & Mufson, E. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102097 · Cited by 20

Regional acetylcholinesterase activity and its correlation with behavioral performances in 15-month old transgenic mice expressing the human C99 fragment of APP

Dumont, M., Lalonde, R., Ghersi‐Egea, J., Fukuchi, K.-I., & Strazielle, C. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0373-6 · Cited by 20

Amyloid beta peptide-induced cholinergic fibres loss in the cerebral cortex of the rat is modified by diet high in lipids and by age

Gonzalo‐Ruiz, A., Sanz, J. M., Arévalo‐Serrano, J., Geula, C., & Gonzalo, P. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.09.005 · Cited by 21

Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review

Cleene, N. D., Schwarzová, K., Labrecque, S., Cerejo, C., Djamshidian, A., Seppi, K., & Heim, B. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1505029 · Cited by 23

Transient disturbances in contextual fear memory induced by Aβ(25–35) in rats are accompanied by cholinergic dysfunction

Stepanichev, M. Y., Лазарева, Н. А., Тухбатова, Г. Р., Salozhin, S. V., & Gulyaeva, N. V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.013 · Cited by 19

Ambient Glutamate Promotes Paroxysmal Hyperactivity in Cortical Pyramidal Neurons at Amyloid Plaques via Presynaptic mGluR1 Receptors

Ovsepian, S. V., Blázquez‐Llorca, L., Valero-Freitag, S., Rodrigues, E. F., & Herms, J. W. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw267 · Cited by 19

Celecoxib effect on rivastigmine anti-Alzheimer activity against aluminum chloride-induced neurobehavioral deficits as a rat model of Alzheimer's disease; novel perspectives for an old drug

Abdel‐Aal, R. A., Hussein, O. A., Elsaady, R. G., & Abdelzaher, L. A. (2021) · Journal of Medical and Life Science · doi:10.21608/jmals.2021.210630 · Cited by 17

Vaccine development for Alzheimer's disease: a shot of good news

Ingram, D. K. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01796-3 · Cited by 18

Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease

Aguilar, L. F., Hall, H., Orciani, C., Foret, M. K., Kovecses, O., Ducatenzeiler, A., & Cuello, A. C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12835 · Cited by 17

Regional brain evaluation of acetylcholinesterase activity in PS1/A246E transgenic mice

Jazi, R., Lalonde, R., Qian, S., & Strazielle, C. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.11.002 · Cited by 18

Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects

Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21

Long‐term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis

Orciani, C., Hall, H., Pentz, R., Foret, M. K., Carmo, S. D., & Cuello, A. C. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15683 · Cited by 16

Nuclear 82-kDa choline acetyltransferase decreases amyloidogenic APP metabolism in neurons from APP/PS1 transgenic mice

Albers, S. S., Inthathirath, F., Gill, S. K., Winick‐Ng, W., Jaworski, E. M., Wong, D. Y. L., Gros, R., & Rylett, R. J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.008 · Cited by 16

Old-onset caloric restriction effects on neuropeptide Y- and somatostatin-containing neurons and on cholinergic varicosities in the rat hippocampal formation

Cardoso, A., Silva, D., Magano, S., Pereira, P. A., & Andrade, J. P. (2014) · AGE · doi:10.1007/s11357-014-9737-x · Cited by 17

Longitudinal Brain Corticotropin Releasing Factor and Somatostatin in a Transgenic Mouse (TG2576) Model of Alzheimer's Disease

Horgan, J., Miguel-Hidalgo, J. J., Thrasher, M., & Bissette, G. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12201 · Cited by 17

Distinct subsets of nucleus basalis neurons exhibit similar sensitivity to excitotoxicity

Harkany, T., Varga, C., Grosche, J., Mulder, J., Luiten, P. G. M., Hortobágyi, T., Penke, B., & Härtig, W. (2002) · Neuroreport · doi:10.1097/00001756-200205070-00007 · Cited by 15

Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimer's disease pathology

Kar, S. (2002) · Drug Development Research · doi:10.1002/ddr.10080 · Cited by 14

The Role of Aβ-Peptide on Spatial Memory, EEG, Auditory Evoked Potentials And Nicotinic Cholinergic Receptors in A/P Transgenic Mice

Wang, J. (2003) · Cited by 14

Nicotine abolishes memory‐related synaptic strengthening and promotes synaptic depression in the neurogenic dentate gyrus of miR‐132/212 knockout mice

Stojanovic, T., Beneš, H., Awad, A., Bormann, D., & Monje, F. J. (2020) · Addiction Biology · doi:10.1111/adb.12905 · Cited by 12

Deficits in Aversive but not in Safe Taste Memory in the APPswe/PS1dE9 mice

Ramı́rez-Lugo, L., Jensen, M. S., Søderman, A., & West, M. J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1141 · Cited by 13

Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice

Luo, G., Xu, H., Huang, Y., Mo, D., Song, L., Jia, B., Wang, B., Jin, Z., & Miao, Z. (2016) · BioMed Research International · doi:10.1155/2016/8380618 · Cited by 11

Does Alzheimer's Disease Result from Attempts at Repair or Protection After Transient Stress?

Bissette, G. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1171 · Cited by 11

Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy

Köhler, C. N., Bista, P., Götz, J., & Schröder, H. C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.076 · Cited by 11

Par-4 induces cholinergic hypoactivity by suppressing ChAT protein synthesis and inhibiting NGF-inducibility of ChAT activity

Guo, Q., Xie, J., & Du, H. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02559-2 · Cited by 11

Deficits in hippocampal‐dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis

Montgomery, K. S., Edwards, G. A., Levites, Y., Kumar, A., Myers, C. E., Gluck, M. A., Setlow, B., & Bizon, J. L. (2015) · Hippocampus · doi:10.1002/hipo.22535 · Cited by 10

Decreased vesicular acetylcholine transporter and α4β2 nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning

Quinlivan, M., Chalon, S., Vergote, J., Henderson, J. M., Katsifis, A. G., Kassiou, M., & Guilloteau, D. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.065 · Cited by 10

Disruption of Cholinergic Circuits as an Area for Targeted Drug Treatment of Alzheimer’s Disease: In Vivo Assessment of Short-Term Plasticity in Rat Brain

Chavushyan, V. A., Soghomonyan, A., Karapetyan, G., Սիմոնյան, Կ. Վ., & Yenkoyan, K. B. (2020) · Pharmaceuticals · doi:10.3390/ph13100297 · Cited by 9

Neuropathological Verisimilitude in Animal Models of Alzheimer's Disease

Trojanowski, J. Q. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64858-4 · Cited by 8

Brain cholinesterases: I. The clinico-histopathological and biochemical basis of Alzheimer's disease

Shen, Z. X. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.032 · Cited by 8

Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β

Gureviciene, I., Gurevicius, K., Mugantseva, E., Kislin, M., Khiroug, L. S., & Tanila, H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160453 · Cited by 8

Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets

Cuello, A. C. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_1 · Cited by 8

Central Cholinergic Synapse Formation in Optimized Primary Septal-Hippocampal Co-cultures

Djemil, S., Ressel, C. R., Abdel‐Ghani, M., Schneeweis, A. K., & Pak, D. T. S. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00948-6 · Cited by 7

Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy

Salehi, A., Kleschevnikov, A. M., & Mobley, W. C. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_5 · Cited by 7

Normal and Abnormal Tau Neurobiology

Duff, K. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213881.01289.d9 · Cited by 7

Alzheimer’s disease: transgenic mouse models and drug assessment

Yu, P., & Oberto, G. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0670 · Cited by 7

Cholinergic Neurotransmission, Amyloid-β Peptide and the Pathogenesis of Alzheimer's Disease

Liu, L. (2003) · Cited by 7

Early Changes in Behavior Deficits, Amyloid β-42 Deposits and MAPK Activation in Doubly Transgenic Mice Co-expressing NSE-Controlled Human Mutant PS2 and APPsw

Hwang, D. Y., Cho, J. S., Oh, J. H., Shim, S. B., Jee, S. W., Lee, S. H., Seo, S. J., Song, C. W., Lee, S. H., & Kim, Y. K. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-4950-x · Cited by 6

High-Caloric Diets in Adolescence Impair Specific GABAergic Subpopulations, Neurogenesis, and Alter Astrocyte Morphology

Mota, B., Brás, A. R., Araújo-Andrade, L., Silva, A., Pereira, P. A., Madeira, M. D., & Cardoso, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105524 · Cited by 5

Aged wild-type littermates and APPswe+PS1/ΔE9 mice present similar deficits in associative learning and spatial memory independent of amyloid load

Park, S., Ko, H., Lee, N., Lee, H., Rim, E. Y., Kim, H., Lee, K., & Kaang, B. (2010) · Genes & Genomics · doi:10.1007/s13258-010-0833-8 · Cited by 5

The promising role of bioactive congeners present in Cassytha filiformis in Alzheimer's disease: An explicative review

Khabiya, R., Karati, D., Dwivedi, S., Dwivedi, A., & Mukherjee, S. (2024) · Brain Disorders · doi:10.1016/j.dscb.2024.100125 · Cited by 4

Effects of wild-type and mutant human amyloid precursor protein on cortical afferent network

Alpár, A., Ueberham, U., Seeger, G., Arendt, T., & Gärtner, U. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282202829 · Cited by 3

Cholinergic Plasticity and the Meaning of Death

McKinney, M., Baskerville, K. A., Personett, D. A., Williams, K., & Gonzales, J. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0282-1_2 · Cited by 3

Selective vulnerability of the aging cholinergic system to amyloid pathology revealed by induced APP overexpression

Xie, K., Ryan, D. P., Schröder, S., Freund, L. J., Bonn, S., Zhou, Y., & Ehninger, D. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03682-2 · Cited by 2

Effects of Aging and Nerve Growth Factor on Neuropeptide Expression and Cholinergic Innervation of the Rat Basolateral Amygdala

Pereira, P. A., Tavares, M., Laires, M., Mota, B., Madeira, M. D., Paula-Barbosa, M. M., & Cardoso, A. (2024) · Biology · doi:10.3390/biology13030155 · Cited by 1

Behavioral and brain morphological analysis of non-inflammatory and inflammatory rat models of preterm brain injury

Rocha, R. F., Araújo-Andrade, L., Alves, T. C. T. F., Sá, S. I., Pereira, P. A., Madeira, M. D., & Cardoso, A. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107540 · Cited by 2

Alzheimer disease models and human neuropathology: similarities and diVerences

Duyckaerts, C. J., Potier, M., & Delatour, B. (2008) · Cited by 2

Mouse Models of Alzheimer’s Disease

German, D. C. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_16 · Cited by 1

Pathogenesis and Mechanism of Cerebral Amyloidosis in APP Transgenic Mice

Jucker, M., Calhoun, M. E., Phinney, A. L., Stalder, M., Bondolfi, L., Winkler, D. T., Herzig, M. C., Pfeifer, M., Boncristiano, S., Tolnay, M., et al. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_6 · Cited by 1

Cortical Cholinergic Lesion Causes Aβ Deposition: Cholinergic-Amyloid Fusion Hypothesis

Beach, T. G., Potter, P. E., Sue, L. I., Newell, A., Poston, M., Cisneros, R., Pandya, Y., Fisher, A., Roher, A. E., Lue, L., et al. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_44

Amyloid Pathology and Cholinergic Networks in Transgenic Models of Alzheimer’s Disease

Cuello, A. C. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_22

INTERACTIONS OF CHOLINERGIC INNERVATION AND SOLUBLE AB42 PEPTIDE METABOLISM IN THE HIPPOCAMPUS

Isanski, B. A. (2007) · D-Scholarship@Pitt (University of Pittsburgh)

Effec ts of hyperoxia in alzheimers transgenic mice

Cox, A. (2005) · Digital Commons - University of South Florida (University of South Florida)

Dissecting out the contribution of cognitive, social, and physical activities to environmental enrichment's ability to protect Alzheimer's mice against cognitive impairment

Cracchiolo, J. R. (2005) · Digital Commons - University of South Florida (University of South Florida)

Effects of Adoptive Transfer of Beta-Amyloid Sensitive Immune Cells in a Mouse Model for Alzheimer’s Disease

Shippy, D. C. (2005) · Digital Commons - University of South Florida (University of South Florida)

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE

Charriez, C. M. (2010) · UKnowledge (University of Kentucky)

Amyloid β-Peptide and Central Cholinergic Neurons: Involvement in Normal Brain Function and Alzheimer’s Disease Pathology

Karn, S., Wei, Z., MacTavish, D., Kabogo, D., Song, M.-S., & Jhamandas, J. H. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_10

Evidence That Amyloid Pathology Progresses in a Neurotransmitter-Specific Manner

Bell, K. F. S., & Cuello, A. C. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_42

Synaptic Pathology in Dementia

Scheff, S. W. (2006) · Springer eBooks · doi:10.1007/978-0-387-32562-0_30

The Rationale for Glutamatergic Therapy in Alzheimer's Disease

Francis, P. T. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_6

The Functions of the Amyloid Precursor Protein Gene and Its Derivative Peptides: II Experimental Evidence and Clinical Studies

Panegyres, P. K., & Atkins, E. (2011) · Neuroscience & Medicine · doi:10.4236/nm.2011.23033

Faire repousser des neurones

Cuello, A. C., & Saragovi, H. U. (2000) · Biofutur · doi:10.1016/s0294-3506(00)88177-6

The cholinergic transmission in the retrosplenial cortex of the epileptic rat

Ferreira, J. L. M. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/6766-nv76

Adaptive responses of central cholinergic systems in transgenic mice

Hartmann, J. (2006) · ThinkTech (Texas Tech University)

O sistema hipocampo-córtex retrosplénico na epilepsia experimental: estudos morfológico e comportamental

Cardoso, A. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/sc5e-2g25

ENRIQUECIMIENTO AMBIENTAL EN RATONES 3xTgAD

Alzheimer, M. D. (2011)

Cerebral amyloid angiopathy : new insights from transgenic mice

Herzig, M. C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003642738

Augusto Claudio Guillermo Cuello

(2001) · The History of neuroscience in autobiography · doi:10.1016/s1874-6055(01)80010-4

A study of the role of presenilin (1) in regulating synaptic function at hippocampal synapses

Yu, L. M. Y. (2010) · UCL Discovery (University College London)

The light at the end of the tunnel : study of early-stage brain dynamics alterations in Alzheimer’s disease and beneficial effects of light stimulation in the AppNL-F/MAPT mouse model

Aguilera, M. (2024) · theses.fr (ABES) · doi:10.70675/dc614591zf8f9z4a6dzb174za8a482fa3ece

Cortical Cholinergic Deafferentation Induces Aβ Deposition

Beach, T. G., Walker, D. G., Potter, P. E., Sue, L. I., Scott, S., Layne, K. J., Newell, A., Rauschkolb, P. K., Poston, M., Webster, S. D., et al. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-896-0_7

Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes

Hernandez, D., Sugaya, K., Qu, T., McGowan, E., Duff, K., & McKinney, M. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00018 · Cited by 73

P3‐047: Cholinergic degenerative pathology in ps1m146l/APP751sl alzheimer transgenic model

Trujillo‐Estrada, L., Sánchez‐Mejías, E., Sanchez-Varo, R. M., DeCastro, V., Anerios, M., Torres, M., Jiménez, S., Vizuete, M., Vitórica, J., & Gutiérrez, A. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.1486

Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis

Boncristiano, S., Calhoun, M. E., Kelly, P. H., Pfeifer, M., Bondolfi, L., Stalder, M., Phinney, A. L., Abramowski, D., Sturchler-Pierrat, C., Enz, A., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03234.2002 · Cited by 160

Acetylcholinesterase-Positive Fiber Deafferentation and Cell Shrinkage in the Septohippocampal Pathway of Aged Amyloid Precursor Protein London Mutant Transgenic Mice

Bronfman, F. C., Moechars, D., & LEUVEN, F. V. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0283 · Cited by 86

Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal Pathway

Jaffar, S., Counts, S., Ma, S. Y., Dadko, E., Gordon, M. N., Morgan, D., & Mufson, E. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7710 · Cited by 93